Related Experiment Video
Updated: Jun 23, 2025

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats
Published on: December 5, 2017
Emerging Roles and Therapeutic Applications of Arachidonic Acid Pathways in Cardiometabolic Diseases
Yufeng Hu1,2, Wei Li3, Xu Cheng1,2
1State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases, Gannan Innovation and Translational Medicine Research Institute, Gannan Medical University, Ganzhou, China (Y.H., X.C., H.Y., Z.-G.S., J.C., H.L., X.-J.Z.).
Insights
Arachidonic acid pathways are key in cardiometabolic diseases like heart failure and diabetes. Targeting these pathways offers new therapeutic strategies for these widespread conditions.
Area of Science:
- Biochemistry
- Cardiovascular Medicine
- Metabolic Disorders
Background:
- Cardiometabolic disease presents a significant global health challenge with limited treatment options.
- Arachidonic acid pathways are increasingly recognized for their role in linking metabolic dysfunction to cardiovascular disease.
- These pathways are implicated in the progression and severity of various cardiometabolic conditions.
Purpose of the Study:
- To systematically review the biological functions of arachidonic acid pathways in major cardiometabolic diseases.
- To elucidate the cellular and molecular mechanisms underlying arachidonic acid pathway regulation in these diseases.
- To highlight emerging clinical strategies targeting arachidonic acid metabolites for improved patient outcomes.
Main Methods:
- Systematic literature review and synthesis of existing research.
- Analysis of cellular and molecular mechanisms.
- Review of current clinical advances and therapeutic targets.
Main Results:
- Arachidonic acid derivatives and pathway factors are integral to heart failure, hypertension, atherosclerosis, nonalcoholic fatty liver disease, obesity, and diabetes.
- Detailed understanding of the molecular and cellular roles of these pathways in disease pathogenesis.
- Identification of potential therapeutic targets within the arachidonic acid pathway.
Conclusions:
- Arachidonic acid pathways are crucial mediators in cardiometabolic disease development and progression.
- Targeting specific arachidonic acid metabolites and pathway factors shows promise for novel therapeutic interventions.
- Further research into these pathways can lead to improved management of cardiometabolic disorders.
Abstract:
Cardiometabolic disease has become a major health burden worldwide, with sharply increasing prevalence but highly limited therapeutic interventions. Emerging evidence has revealed that arachidonic acid derivatives and pathway factors link metabolic disorders to cardiovascular risks and intimately participate in the progression and severity of cardiometabolic diseases. In this review, we systemically summarized and updated the biological functions of arachidonic acid pathways in cardiometabolic diseases, mainly focusing on heart failure, hypertension, atherosclerosis, nonalcoholic fatty liver disease, obesity, and diabetes. We further discussed the cellular and molecular mechanisms of arachidonic acid pathway-mediated regulation of cardiometabolic diseases and highlighted the emerging clinical advances to improve these pathological conditions by targeting arachidonic acid metabolites and pathway factors.
More Related Videos
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
Related Concept Videos
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
The JAK-STAT Signaling Pathway